Viewing Study NCT00520169


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2026-04-09 @ 11:01 AM
Study NCT ID: NCT00520169
Status: COMPLETED
Last Update Posted: 2008-01-10
First Post: 2007-08-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine
Sponsor: Javelin Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module